ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
39.98
0.86%
US Tech 100
20,877.20
1.72%
S&P 500
5,996.66
1.00%
US Dollar vs CAD
1.44905
0.03%
Bitcoin
103,086.51
-1.00%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Tonix Pharmaceuticals Holding Corporation (TNXP)

  7. Tonix Pharmaceuticals Holding Corporation (TNXP) News

TNXP

Tonix Pharmaceuticals (TNXP)

Tonix Pharmaceuticals Holding Corporation
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:TNXP
DateTimeSourceHeadlineSymbolCompany
01/08/20256:39AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
01/08/20256:00AMGlobeNewswire Inc.Tonix Pharmaceuticals Further Strengthens Commercial Leadership Team with Appointment of Gary Ainsworth as Vice President of Market AccessNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
01/07/20256:00AMGlobeNewswire Inc.Tonix Pharmaceuticals to Present at Two Upcoming January Investor ConferencesNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
01/03/20251:56PMEdgar (US Regulatory)Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
12/23/20247:05AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
12/23/20247:00AMGlobeNewswire Inc.Tonix Pharmaceuticals Announces PDUFA Goal Date of August 15, 2025, for FDA Decision on U.S. Marketing Approval for TNX-102 SL for FibromyalgiaNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
12/20/20243:17PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
12/20/20243:16PMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
12/17/20248:25AMAllPennyStocks.comThis Micro Cap Is Getting Bid Up Prior To Opening BellNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
12/17/20247:05AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
12/17/20247:00AMGlobeNewswire Inc.Tonix Pharmaceuticals Announces FDA Acceptance of the New Drug Application (NDA) for TNX-102 SL for FibromyalgiaNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
12/06/20243:13PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
12/03/20246:05AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
12/03/20246:00AMGlobeNewswire Inc.Tonix Pharmaceuticals Announces Expansion of Leadership Team with Two Strategic HiresNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
11/26/20246:00AMGlobeNewswire Inc.Tonix Pharmaceuticals to Participate in the NobleCon20 Investor ConferenceNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
11/18/20243:05PMGlobeNewswire Inc.Tonix Pharmaceuticals to Present at the Winter 2024 Investor Summit VirtualNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
11/18/20246:00AMGlobeNewswire Inc.Tonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on Fibromyalgia at the American College of Rheumatology (ACR) Convergence 2024 Annual MeetingNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
11/14/20243:42PMEdgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
11/14/20243:40PMEdgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
11/13/20243:05PMGlobeNewswire Inc.Tonix Pharmaceuticals Announces Poster Presentation at the American College of Rheumatology (ACR) Convergence 2024 Annual MeetingNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
11/13/20248:10AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
11/13/20248:05AMGlobeNewswire Inc.Tonix Pharmaceuticals Announces Peer-Reviewed Publication in mSphere Journal Highlighting the Tolerability of Company’s Single-Dose Mpox and Smallpox Vaccine Candidate TNX-801, in Immune-Compromised AnimalsNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
11/12/20244:10PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
11/12/20247:05AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
11/12/20247:00AMGlobeNewswire Inc.Tonix Pharmaceuticals Reports Third Quarter 2024 Financial Results and Operational HighlightsNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
11/08/20244:15PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
11/04/20246:30AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
11/04/20246:00AMGlobeNewswire Inc.Tonix Pharmaceuticals Announces Research Agreement with Kenya Medical Research Institute (KEMRI) to Design, Plan and Seek Regulatory Approval for a Phase I Clinical Study of TNX-801 for Mpox in KenyaNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
11/01/20246:05AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
11/01/20246:00AMGlobeNewswire Inc.Tonix Pharmaceuticals Presented Data on Potential Mpox Vaccine TNX-801 at World Vaccine Congress-Europe 2024NASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
 Showing the most relevant articles for your search:NASDAQ:TNXP

Your Recent History

TG
CZ45YV
Commerzbank
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads